ETFs holding Bicara Therapeutics Inc. stocks
Below are funds with Bicara Therapeutics Inc. stocks, sorted by market value. Equipped with price, change, and other helpful stats, they make investing in BCAX more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 IWNiShares Russell 2000 Value ETF | 3.24 M USD | 0.03% | BlackRock, Inc. | Passive | Small cap | 0.24% | 12.03 B USD | 175.10 USD | −1.00% | 0.76 | +44.65% |
 FESMFidelity Enhanced Small Cap ETF | 930.62 K USD | 0.04% | FMR LLC | Active | Small cap | 0.28% | 2.52 B USD | 36.15 USD | −0.66% | 0.75 | +74.67% |
 VHTVanguard Health Care ETF | 688.79 K USD | 0.00% | The Vanguard Group, Inc. | Passive | Health care | 0.09% | 15.13 B USD | 250.29 USD | −1.61% | 1.45 | +19.07% |
 SBIOALPS Medical Breakthroughs ETF | 298.28 K USD | 0.33% | SS&C Technologies Holdings, Inc. | Passive | Health care | 0.50% | 89.62 M USD | 36.84 USD | −1.56% | 0.72 | +36.19% |
 TMSLT. Rowe Price Small-Mid Cap ETF | 282.7 K USD | 0.03% | T. Rowe Price Group, Inc. | Active | Extended market | 0.55% | 957.59 M USD | 34.74 USD | −0.77% | 0.45 | +8.46% |
| VTWVVanguard Russell 2000 Value ETF | 247.17 K USD | 0.03% | The Vanguard Group, Inc. | Passive | Small cap | 0.10% | 839.18 M USD | 154.29 USD | −0.90% | 0.64 | +45.56% |
 BBCVirtus LifeSci Biotech Clinical Trials ETF | 110.05 K USD | 0.65% | Virtus Investment Partners, Inc. | Passive | Health care | 0.79% | 16.41 M USD | 25.65 USD | −1.65% | 0.35 | +15.62% |
 BBSCJPMorgan BetaBuilders U.S. Small Cap Equity Fund | 109.48 K USD | 0.02% | JPMorgan Chase & Co. | Passive | Small cap | 0.09% | 589.05 M USD | 73.34 USD | −1.05% | 3.37 | +58.99% |
 WCEOHypatia Women CEO ETF | 10.29 K USD | 0.19% | Hypatia Capital Group LLC | Active | Total market | 0.85% | 5.54 M USD | 32.15 USD | −0.90% | 0.29 | +7.28% |